EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor

Nesreen F Alkhofash iD, Bassam R Ali iD

Biomolecules · 2024

DOI: 10.3390/biom14070764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Nesreen F Alkhofash und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain P.O. Box 15551, United Arab Emi…. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, SARS-CoV-2, COVID-19 Drug Treatment, Protein Transport. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ASPIRE Precision Medicine Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ACE2, part of the angiotensin-converting enzyme family and the renin–angiotensin–aldosterone system (RAAS), plays vital roles in cardiovascular and renal functions. It is also the primary receptor for SARS-CoV-2, enabling its entry into cells. This project aimed to study ACE2’s cellular trafficking and maturation to the cell surface and assess the impact of various drugs and compounds on these processes. We used cellular and biochemical analyses to evaluate these compounds as potential leads for COVID-19 therapeutics. Our screening assay focused on ACE2 maturation levels and subcellular localization with and without drug treatments. Results showed that ACE2 maturation is generally fast and robust, with certain drugs having a mild impact. Out of twenty-three tested compounds, eight significantly reduced ACE2 maturation levels, and three caused approximately 20% decreases. Screening trafficking inhibitors revealed significant effects from most molecular modulators of protein trafficking, mild effects from most proposed COVID-19 drugs, and no effects from statins. This study noted that manipulating ACE2 levels could be beneficial or harmful, depending on the context. Thus, using this approach to uncover leads for COVID-19 therapeutics requires a thorough understanding ACE2’s biogenesis and biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2SARS-CoV-2COVID-19 Drug TreatmentProtein TransportHumansAntiviral AgentsCOVID-19HEK293 CellsDrug Evaluation, Preclinical

Stichwörter der Autor:innen

ACE2COVID-19cellular localizationdrugs screeningmolecular modulators of transportationprotein trafficking

Substanzen

Angiotensin-Converting Enzyme 2ACE2 protein, humanAntiviral Agents

Autor:innen und Institutionen

  • Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain P.O. Box 15551, United Arab Emirates.
  • ASPIRE Precision Medicine Research Institute Abu Dhabi, United Arab Emirates University, Al-Ain P.O. Box 15551, United Arab Emirates.

ORCID-Profile: Nesreen F Alkhofash, Bassam R Ali

Förderung

  • ASPIRE Precision Medicine Research Institute

Zitieren

APA

Alkhofash, N. F., & Ali, B. R. (2024). The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor. Biomolecules. https://doi.org/10.3390/biom14070764

Vancouver

Alkhofash NF, Ali BR. The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor. Biomolecules. 2024. doi:10.3390/biom14070764

BibTeX
@article{Alkhofash2024,
  author = {Alkhofash, Nesreen F and Ali, Bassam R},
  title = {The Evaluation of Drugs as Potential Modulators of the Trafficking and Maturation of ACE2, the SARS-CoV-2 Receptor},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14070764}
}
Kostenlos starten →